← Back to Search

Diagnostic Device

Biopsy for Prostate Cancer

N/A

Waitlist Available

Led By Fergus V Coakley

Research Sponsored by OHSU Knight Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 30 days after end of procedure

Awards & highlights

Study Summary

This trial tests whether a new device that allows for both imaging and biopsy of the prostate during the same MRI procedure is feasible.

Eligible Conditions

Prostate Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 30 days after end of procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 30 days after end of procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 30 days after end of procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence of biopsy-related grade >= 3 adverse events (early feasibility study)

Incidence of biopsy-related grade >= 3 adverse events (traditional feasibility study)

Physician device-user scores (early feasibility study)

+3 more

Side effects data

From 2015 Phase 2 trial • 59 Patients • NCT02150213

Renal Cyst

Adrenal Adenoma

Angiomyolipoma

Ovarian cyst

100%

80%

60%

40%

20%

Study treatment Arm

BGG492

Trial Design

1Treatment groups

Experimental Treatment

Group I: Diagnostic (endorectal MRI, MRI-targeted biopsy)Experimental Treatment2 Interventions

Patients undergo endorectal MRI and transrectal MRI-targeted biopsy using the OmnEcoil device.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Biopsy

2014

Completed Phase 4

~1090

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

OHSU Knight Cancer InstituteLead Sponsor

231 Previous Clinical Trials

2,090,646 Total Patients Enrolled

26 Trials studying Prostate Cancer

2,388 Patients Enrolled for Prostate Cancer

Oregon Health and Science UniversityOTHER

978 Previous Clinical Trials

7,386,459 Total Patients Enrolled

20 Trials studying Prostate Cancer

7,321 Patients Enrolled for Prostate Cancer

U.S. National Science FoundationFED

34 Previous Clinical Trials

8,826 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for this research project?

"Sources on clinicaltrials.gov disclose that this trial is no longer accepting patients, despite being initially posted in February 1st 2023 and having been recently updated on October 26th 2022. However, there are presently 1321 other medical studies actively recruiting new candidates."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate

Fergus Coakley 2023. "Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05362032.